APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma Fractionation and Blood Product

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Plasma Fractionation and Blood Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026195 pages

Choose your research edition.

Industry ResearchPlasma Fractionation and Blood Product Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Fractionation and Blood Product Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Plasma Fractionation and Blood Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Fractionation and Blood Product Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Fractionation and Blood Product Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Plasma Fractionation and Blood Product market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Plasma Fractionation and Blood Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plasma Fractionation and Blood Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasma Fractionation and Blood Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Plasma Fractionation and Blood Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Plasma Fractionation and Blood Product include Takeda, RAAS, Octapharma, LFB Group, Kedrion, Hualan Bio, Grifols, CSL and CBPO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Plasma Fractionation and Blood Product market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plasma Fractionation and Blood Product and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plasma Fractionation and Blood Product sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plasma Fractionation and Blood Product market size, projected growth trends, production technologies, key applications, and end-use industries.

Plasma Fractionation and Blood Product Segment by Company

Takeda

RAAS

Octapharma

LFB Group

Kedrion

Hualan Bio

Grifols

CSL

CBPO

BPL

Biotest

Plasma Fractionation and Blood Product Segment by Type

Albumin

Immune Globulin

Coagulation Factor

Other

Plasma Fractionation and Blood Product Segment by Application

Immunology

Hematology

Other

Plasma Fractionation and Blood Product Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Fractionation and Blood Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Fractionation and Blood Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Fractionation and Blood Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plasma Fractionation and Blood Product market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Plasma Fractionation and Blood Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Plasma Fractionation and Blood Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Plasma Fractionation and Blood Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Plasma Fractionation and Blood Product Industry Trends Table 2. Plasma Fractionation and Blood Product Industry Drivers Table 3. Plasma Fractionation and Blood Product Industry Opportunities and Challenges Table 4. Plasma Fractionation and Blood Product Industry Restraints Table 5. Global Plasma Fractionation and Blood Product Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Plasma Fractionation and Blood Product Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Plasma Fractionation and Blood Product Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturers Table 9. Global Plasma Fractionation and Blood Product Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Plasma Fractionation and Blood Product Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Plasma Fractionation and Blood Product Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Plasma Fractionation and Blood Product Manufacturers, Product Type & Application Table 13. Global Plasma Fractionation and Blood Product Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Plasma Fractionation and Blood Product by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Albumin Table 17. Major Manufacturers of Immune Globulin Table 18. Major Manufacturers of Coagulation Factor Table 19. Major Manufacturers of Other Table 20. Global Plasma Fractionation and Blood Product Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (K Units) Table 22. Global Plasma Fractionation and Blood Product Sales by Type (2027-2032) & (K Units) Table 23. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2021-2026) Table 24. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2027-2032) Table 25. Global Plasma Fractionation and Blood Product Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Plasma Fractionation and Blood Product Revenue by Type (2021-2026) & (K Units) Table 27. Global Plasma Fractionation and Blood Product Revenue by Type (2027-2032) & (K Units) Table 28. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2021-2026) Table 29. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Immunology Table 31. Major Manufacturers of Hematology Table 32. Major Manufacturers of Other Table 33. Global Plasma Fractionation and Blood Product Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (K Units) Table 35. Global Plasma Fractionation and Blood Product Sales by Application (2027-2032) & (K Units) Table 36. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2021-2026) Table 37. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2027-2032) Table 38. Global Plasma Fractionation and Blood Product Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Plasma Fractionation and Blood Product Revenue by Application (2021-2026) & (K Units) Table 40. Global Plasma Fractionation and Blood Product Revenue by Application (2027-2032) & (K Units) Table 41. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2021-2026) Table 42. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2027-2032) Table 43. Global Plasma Fractionation and Blood Product Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Plasma Fractionation and Blood Product Sales by Region (2021-2026) & (K Units) Table 45. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2021-2026) Table 46. Global Plasma Fractionation and Blood Product Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Plasma Fractionation and Blood Product Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Plasma Fractionation and Blood Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units) Table 50. North America Plasma Fractionation and Blood Product Sales by Country (2027-2032) & (K Units) Table 51. Europe Plasma Fractionation and Blood Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units) Table 53. Europe Plasma Fractionation and Blood Product Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Plasma Fractionation and Blood Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Plasma Fractionation and Blood Product Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Plasma Fractionation and Blood Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2027-2032) & (K Units) Table 60. Global Plasma Fractionation and Blood Product Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Plasma Fractionation and Blood Product Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Plasma Fractionation and Blood Product Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2021-2026) Table 64. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2027-2032) Table 65. Takeda Company Information Table 66. Takeda Business Overview Table 67. Takeda Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Takeda Plasma Fractionation and Blood Product Product Portfolio Table 69. Takeda Recent Development Table 70. RAAS Company Information Table 71. RAAS Business Overview Table 72. RAAS Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. RAAS Plasma Fractionation and Blood Product Product Portfolio Table 74. RAAS Recent Development Table 75. Octapharma Company Information Table 76. Octapharma Business Overview Table 77. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Octapharma Plasma Fractionation and Blood Product Product Portfolio Table 79. Octapharma Recent Development Table 80. LFB Group Company Information Table 81. LFB Group Business Overview Table 82. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. LFB Group Plasma Fractionation and Blood Product Product Portfolio Table 84. LFB Group Recent Development Table 85. Kedrion Company Information Table 86. Kedrion Business Overview Table 87. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Kedrion Plasma Fractionation and Blood Product Product Portfolio Table 89. Kedrion Recent Development Table 90. Hualan Bio Company Information Table 91. Hualan Bio Business Overview Table 92. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Hualan Bio Plasma Fractionation and Blood Product Product Portfolio Table 94. Hualan Bio Recent Development Table 95. Grifols Company Information Table 96. Grifols Business Overview Table 97. Grifols Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Grifols Plasma Fractionation and Blood Product Product Portfolio Table 99. Grifols Recent Development Table 100. CSL Company Information Table 101. CSL Business Overview Table 102. CSL Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. CSL Plasma Fractionation and Blood Product Product Portfolio Table 104. CSL Recent Development Table 105. CBPO Company Information Table 106. CBPO Business Overview Table 107. CBPO Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. CBPO Plasma Fractionation and Blood Product Product Portfolio Table 109. CBPO Recent Development Table 110. BPL Company Information Table 111. BPL Business Overview Table 112. BPL Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. BPL Plasma Fractionation and Blood Product Product Portfolio Table 114. BPL Recent Development Table 115. Biotest Company Information Table 116. Biotest Business Overview Table 117. Biotest Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Biotest Plasma Fractionation and Blood Product Product Portfolio Table 119. Biotest Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Plasma Fractionation and Blood Product Distributors List Table 123. Plasma Fractionation and Blood Product Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Plasma Fractionation and Blood Product Product Image Figure 2. Global Plasma Fractionation and Blood Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Fractionation and Blood Product Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasma Fractionation and Blood Product Sales (2021-2032) & (K Units) Figure 5. Global Plasma Fractionation and Blood Product Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Plasma Fractionation and Blood Product Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Albumin Image Figure 9. Immune Globulin Image Figure 10. Coagulation Factor Image Figure 11. Other Image Figure 12. Global Plasma Fractionation and Blood Product Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Plasma Fractionation and Blood Product Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2021-2032) Figure 15. Global Plasma Fractionation and Blood Product Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Plasma Fractionation and Blood Product Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2021-2032) Figure 18. Immunology Image Figure 19. Hematology Image Figure 20. Other Image Figure 21. Global Plasma Fractionation and Blood Product Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Plasma Fractionation and Blood Product Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2021-2032) Figure 24. Global Plasma Fractionation and Blood Product Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Plasma Fractionation and Blood Product Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2021-2032) Figure 27. North America Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2032) Figure 29. U.S. Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2032) Figure 34. Germany Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2032) Figure 41. China Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2032) Figure 49. Brazil Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Plasma Fractionation and Blood Product Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Plasma Fractionation and Blood Product Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Plasma Fractionation and Blood Product Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Plasma Fractionation and Blood Product Revenue (2021-2032) & (US$ Million) Figure 60. North America Plasma Fractionation and Blood Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Plasma Fractionation and Blood Product Revenue (2021-2032) & (US$ Million) Figure 62. Europe Plasma Fractionation and Blood Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Plasma Fractionation and Blood Product Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Plasma Fractionation and Blood Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Plasma Fractionation and Blood Product Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Plasma Fractionation and Blood Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Plasma Fractionation and Blood Product Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Plasma Fractionation and Blood Product Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Albumin
  • Immune Globulin
  • Coagulation Factor
  • Other
Applications
  • Immunology
  • Hematology
  • Other
Companies covered
  • Takeda
  • RAAS
  • Octapharma
  • LFB Group
  • Kedrion
  • Hualan Bio
  • Grifols
  • CSL
  • CBPO
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Plasma Fractionation and Blood Product Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Plasma Fractionation and Blood Product Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Plasma Fractionation and Blood Product Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Plasma Fractionation and Blood Product Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Plasma Fractionation and Blood Product Market Dynamics
  1. 2.1 Plasma Fractionation and Blood Product Industry Trends
  2. 2.2 Plasma Fractionation and Blood Product Industry Drivers
  3. 2.3 Plasma Fractionation and Blood Product Industry Opportunities and Challenges
  4. 2.4 Plasma Fractionation and Blood Product Industry Restraints
3 Plasma Fractionation and Blood Product Market by Manufacturers
  1. 3.1 Global Plasma Fractionation and Blood Product Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Plasma Fractionation and Blood Product Sales by Manufacturers (2021-2026)
  3. 3.3 Global Plasma Fractionation and Blood Product Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Plasma Fractionation and Blood Product Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Plasma Fractionation and Blood Product Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Plasma Fractionation and Blood Product Manufacturers, Product Type & Application
  7. 3.7 Global Plasma Fractionation and Blood Product Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Plasma Fractionation and Blood Product Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Plasma Fractionation and Blood Product Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Plasma Fractionation and Blood Product Tier 1, Tier 2, and Tier 3
4 Plasma Fractionation and Blood Product Market by Type
  1. 4.1 Plasma Fractionation and Blood Product Type Introduction
  2. 4.1.1 Albumin
  3. 4.1.2 Immune Globulin
  4. 4.1.3 Coagulation Factor
  5. 4.1.4 Other
  6. 4.2 Global Plasma Fractionation and Blood Product Sales by Type
  7. 4.2.1 Global Plasma Fractionation and Blood Product Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Plasma Fractionation and Blood Product Sales by Type (2021-2032)
  9. 4.2.3 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2021-2032)
  10. 4.3 Global Plasma Fractionation and Blood Product Revenue by Type
  11. 4.3.1 Global Plasma Fractionation and Blood Product Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Plasma Fractionation and Blood Product Revenue by Type (2021-2032)
  13. 4.3.3 Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2021-2032)
5 Plasma Fractionation and Blood Product Market by Application
  1. 5.1 Plasma Fractionation and Blood Product Application Introduction
  2. 5.1.1 Immunology
  3. 5.1.2 Hematology
  4. 5.1.3 Other
  5. 5.2 Global Plasma Fractionation and Blood Product Sales by Application
  6. 5.2.1 Global Plasma Fractionation and Blood Product Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plasma Fractionation and Blood Product Sales by Application (2021-2032)
  8. 5.2.3 Global Plasma Fractionation and Blood Product Sales Market Share by Application (2021-2032)
  9. 5.3 Global Plasma Fractionation and Blood Product Revenue by Application
  10. 5.3.1 Global Plasma Fractionation and Blood Product Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Plasma Fractionation and Blood Product Revenue by Application (2021-2032)
  12. 5.3.3 Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2021-2032)
6 Global Plasma Fractionation and Blood Product Sales by Region
  1. 6.1 Global Plasma Fractionation and Blood Product Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plasma Fractionation and Blood Product Sales by Region (2021-2032)
  3. 6.2.1 Global Plasma Fractionation and Blood Product Sales by Region (2021-2026)
  4. 6.2.2 Global Plasma Fractionation and Blood Product Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Plasma Fractionation and Blood Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Plasma Fractionation and Blood Product Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Plasma Fractionation and Blood Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Plasma Fractionation and Blood Product Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Plasma Fractionation and Blood Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Plasma Fractionation and Blood Product Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Plasma Fractionation and Blood Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Plasma Fractionation and Blood Product Revenue by Region
  1. 7.1 Global Plasma Fractionation and Blood Product Revenue by Region
  2. 7.1.1 Global Plasma Fractionation and Blood Product Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Plasma Fractionation and Blood Product Revenue by Region (2021-2026)
  4. 7.1.3 Global Plasma Fractionation and Blood Product Revenue by Region (2027-2032)
  5. 7.1.4 Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Plasma Fractionation and Blood Product Revenue (2021-2032)
  8. 7.2.2 North America Plasma Fractionation and Blood Product Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Plasma Fractionation and Blood Product Revenue (2021-2032)
  11. 7.3.2 Europe Plasma Fractionation and Blood Product Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Plasma Fractionation and Blood Product Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Plasma Fractionation and Blood Product Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Plasma Fractionation and Blood Product Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Plasma Fractionation and Blood Product Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Plasma Fractionation and Blood Product Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 RAAS
  8. 8.2.1 RAAS Company Information
  9. 8.2.2 RAAS Business Overview
  10. 8.2.3 RAAS Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 RAAS Plasma Fractionation and Blood Product Product Portfolio
  12. 8.2.5 RAAS Recent Developments
  13. 8.3 Octapharma
  14. 8.3.1 Octapharma Company Information
  15. 8.3.2 Octapharma Business Overview
  16. 8.3.3 Octapharma Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Octapharma Plasma Fractionation and Blood Product Product Portfolio
  18. 8.3.5 Octapharma Recent Developments
  19. 8.4 LFB Group
  20. 8.4.1 LFB Group Company Information
  21. 8.4.2 LFB Group Business Overview
  22. 8.4.3 LFB Group Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 LFB Group Plasma Fractionation and Blood Product Product Portfolio
  24. 8.4.5 LFB Group Recent Developments
  25. 8.5 Kedrion
  26. 8.5.1 Kedrion Company Information
  27. 8.5.2 Kedrion Business Overview
  28. 8.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kedrion Plasma Fractionation and Blood Product Product Portfolio
  30. 8.5.5 Kedrion Recent Developments
  31. 8.6 Hualan Bio
  32. 8.6.1 Hualan Bio Company Information
  33. 8.6.2 Hualan Bio Business Overview
  34. 8.6.3 Hualan Bio Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hualan Bio Plasma Fractionation and Blood Product Product Portfolio
  36. 8.6.5 Hualan Bio Recent Developments
  37. 8.7 Grifols
  38. 8.7.1 Grifols Company Information
  39. 8.7.2 Grifols Business Overview
  40. 8.7.3 Grifols Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Grifols Plasma Fractionation and Blood Product Product Portfolio
  42. 8.7.5 Grifols Recent Developments
  43. 8.8 CSL
  44. 8.8.1 CSL Company Information
  45. 8.8.2 CSL Business Overview
  46. 8.8.3 CSL Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CSL Plasma Fractionation and Blood Product Product Portfolio
  48. 8.8.5 CSL Recent Developments
  49. 8.9 CBPO
  50. 8.9.1 CBPO Company Information
  51. 8.9.2 CBPO Business Overview
  52. 8.9.3 CBPO Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CBPO Plasma Fractionation and Blood Product Product Portfolio
  54. 8.9.5 CBPO Recent Developments
  55. 8.10 BPL
  56. 8.10.1 BPL Company Information
  57. 8.10.2 BPL Business Overview
  58. 8.10.3 BPL Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 BPL Plasma Fractionation and Blood Product Product Portfolio
  60. 8.10.5 BPL Recent Developments
  61. 8.11 Biotest
  62. 8.11.1 Biotest Company Information
  63. 8.11.2 Biotest Business Overview
  64. 8.11.3 Biotest Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biotest Plasma Fractionation and Blood Product Product Portfolio
  66. 8.11.5 Biotest Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Plasma Fractionation and Blood Product Value Chain Analysis
  2. 9.1.1 Plasma Fractionation and Blood Product Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Plasma Fractionation and Blood Product Production Mode & Process
  6. 9.2 Plasma Fractionation and Blood Product Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Plasma Fractionation and Blood Product Distributors
  9. 9.2.3 Plasma Fractionation and Blood Product Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst